Literature DB >> 19098855

Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.

Nele Friedrich1, Henry Völzke, Jochen Hampe, Markus M Lerch, Torben Jørgensen.   

Abstract

OBJECTIVES: Gallstones are a common disease worldwide, with disparities in the prevalence of the disease in different settings. The aim of the present study was to assess if different distributions of risk factors could explain the disparities in the prevalence of gallstone disease between Denmark and northeast Germany.
METHODS: Data of 5,559 subjects from the Danish MONICA survey and of 3,647 subjects of the German Study of Health in Pomerania were investigated. Gallstone disease was defined as a prior history of cholecystectomy or the presence of sonographically diagnosed gallstones. Logistic regression models were performed to assess the confounding effect of selected risk factors on regional disparities in gallstone disease.
RESULTS: After adjustment for age and vocational training, German subjects (women: Odds ratio, OR, 2.46 (95% confidence interval, CI: 2.07-2.91); men: OR, 1.89 (95% CI: 1.52-2.36)) had approximatively twice the odds of gallstones than Danes. Inclusion of lifestyle factors (smoking, alcohol intake, coffee use) did not affect this result, whereas adjustment for body mass index (BMI), lipids, diabetes, and use of oral contraceptives, menopausal hormone therapy (MHT) and parity (women only) changed the estimates considerable, but still Germans (women: OR, 1.65 (95% CI: 1.36-2.00); men: OR, 1.61 (95% CI: 1.27-2.04)) had higher odds than Danes.
CONCLUSIONS: German individuals had a higher prevalence of gallstones than Danes. This difference was partly explained by a higher BMI, unfavorable lipid levels, higher prevalence of diabetes, and a more frequent use of OR and MHT in German subjects. Further research is needed to evaluate the impact of unmeasured predictors, including genetic components, on the population-related risk of gallstones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19098855     DOI: 10.1038/ajg.2008.13

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006.

Authors:  James P Dolan; Brian S Diggs; Brett C Sheppard; John G Hunter
Journal:  J Gastrointest Surg       Date:  2009-09-02       Impact factor: 3.452

2.  Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.

Authors:  Min-Sun Kwak; Donghee Kim; Goh Eun Chung; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  A population-based cohort study of symptomatic gallstone disease in diabetic patients.

Authors:  Chi-Ming Liu; Chung-Te Hsu; Chung-Yi Li; Chu-Chieh Chen; Meng-Lun Liu; Jorn-Hon Liu
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

4.  Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Authors:  Antoine Racine; Anne Bijon; Agnès Fournier; Sylvie Mesrine; Françoise Clavel-Chapelon; Franck Carbonnel; Marie-Christine Boutron-Ruault
Journal:  CMAJ       Date:  2013-03-18       Impact factor: 8.262

Review 5.  Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review.

Authors:  Lujie Chen; Yu-Ting Peng; Fu-Li Chen; Tao-Hsin Tung
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

6.  Clinical impact of body mass index on bactibilia and bacteremia.

Authors:  Chang Seok Bang; Jai Hoon Yoon; Youn Jeong Kim; Jin Bong Kim; Gwang Ho Baik; Ki Tae Suk; Yeon Soo Kim; Dong Joon Kim
Journal:  BMC Gastroenterol       Date:  2014-06-05       Impact factor: 3.067

7.  Risk factors for requiring cholecystectomy for gallstone disease in a prospective population-based cohort study.

Authors:  A Talseth; E Ness-Jensen; T-H Edna; K Hveem
Journal:  Br J Surg       Date:  2016-05-25       Impact factor: 6.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.